US FDA seeks comments on Bacillus species IVD classification guidance
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration has issued for comment a draft special controls guidance document that supports its proposal to classify in vitro diagnostics for detecting Bacillus species as a Class II device1.